Literature DB >> 19702866

MLST clustering of Campylobacter jejuni isolates from patients with gastroenteritis, reactive arthritis and Guillain-Barré syndrome.

L N Nielsen1, S K Sheppard, N D McCarthy, M C J Maiden, H Ingmer, K A Krogfelt.   

Abstract

AIMS: To determine the diversity and population structure of Campylobacter jejuni (C. jejuni) isolates from Danish patients and to examine the association between multilocus sequence typing types and different clinical symptoms including gastroenteritis (GI), Guillain-Barré syndrome (GBS) and reactive arthritis (RA). METHODS AND
RESULTS: Multilocus sequence typing (MLST) was used to characterize 122 isolates, including 18 from patients with RA and 8 from patients with GBS. The GI and RA isolates were collected in Denmark during 2002-2003 and the GBS isolates were obtained from other countries. In overall, 51 sequence types (STs) were identified within 18 clonal complexes (CCs). Of these three CCs, ST-21, ST-45 and ST-22 clonal complexes accounted for 64 percent of all isolates. The GBS isolates in this study significantly grouped into the ST-22 clonal complex, consistent with the PubMLST database isolates. There was no significant clustering of the RA isolates.
CONCLUSIONS: Isolates from Denmark were found to be highly genetically diverse. GBS isolates grouped significantly with clonal complex ST-22, but the absence of clustering of RA isolates indicated that the phylogenetic background for this sequela could not be reconstructed using variation in MLST loci. Possibly, putative RA-associated genes may vary, by recombination or expression differences, independent of MLST loci. SIGNIFICANCE AND IMPACT OF THE STUDY: MLST typing of C. jejuni isolates from Danish patients with gastroenteritis confirmed that the diversity of clones in Denmark is comparable to that in other European countries. Furthermore, a verification of the grouping of GBS isolates compared to RA isolates provides information about evolution of the bacterial population resulting in this important sequela.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19702866      PMCID: PMC3985121          DOI: 10.1111/j.1365-2672.2009.04444.x

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  27 in total

1.  Risk factors for sporadic Campylobacter infections: results of a case-control study in southeastern Norway.

Authors:  G Kapperud; E Skjerve; N H Bean; S M Ostroff; J Lassen
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

2.  Multilocus sequence typing of Campylobacter jejuni isolates from New South Wales, Australia.

Authors:  L Mickan; R Doyle; M Valcanis; K E Dingle; L Unicomb; J Lanser
Journal:  J Appl Microbiol       Date:  2007-01       Impact factor: 3.772

3.  Inference of bacterial microevolution using multilocus sequence data.

Authors:  Xavier Didelot; Daniel Falush
Journal:  Genetics       Date:  2006-12-06       Impact factor: 4.562

4.  Ganglioside GM1 mimicry in Campylobacter strains from sporadic infections in the United States.

Authors:  I Nachamkin; H Ung; A P Moran; D Yoo; M M Prendergast; M A Nicholson; K Sheikh; T Ho; A K Asbury; G M McKhann; J W Griffin
Journal:  J Infect Dis       Date:  1999-05       Impact factor: 5.226

5.  Sequence typing and comparison of population biology of Campylobacter coli and Campylobacter jejuni.

Authors:  Kate E Dingle; Frances M Colles; Daniel Falush; Martin C J Maiden
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

6.  Longitudinal study of Finnish Campylobacter jejuni and C. coli isolates from humans, using multilocus sequence typing, including comparison with epidemiological data and isolates from poultry and cattle.

Authors:  Rauni Kärenlampi; Hilpi Rautelin; Daniela Schönberg-Norio; Lars Paulin; Marja-Liisa Hänninen
Journal:  Appl Environ Microbiol       Date:  2006-11-03       Impact factor: 4.792

7.  Epidemiology, relative invasive ability, molecular characterization, and competitive performance of Campylobacter jejuni strains in the chicken gut.

Authors:  Christopher Pope; Janet Wilson; Eduardo N Taboada; Joanne Mackinnon; Cristiano A Felipe Alves; John H E Nash; Kris Rahn; Gerald W Tannock
Journal:  Appl Environ Microbiol       Date:  2007-10-05       Impact factor: 4.792

8.  Multilocus sequence typing for comparison of veterinary and human isolates of Campylobacter jejuni.

Authors:  Georgina Manning; Christopher G Dowson; Mary C Bagnall; If H Ahmed; Malcolm West; Diane G Newell
Journal:  Appl Environ Microbiol       Date:  2003-11       Impact factor: 4.792

Review 9.  Campylobacter species and Guillain-Barré syndrome.

Authors:  I Nachamkin; B M Allos; T Ho
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

10.  Campylobacter jejuni multilocus sequence types in humans, northwest England, 2003-2004.

Authors:  Will Sopwith; Andrew Birtles; Margaret Matthews; Andrew Fox; Steven Gee; Michael Painter; Martyn Regan; Qutub Syed; Eric Bolton
Journal:  Emerg Infect Dis       Date:  2006-10       Impact factor: 6.883

View more
  22 in total

1.  Impact of Eimeria tenella Coinfection on Campylobacter jejuni Colonization of the Chicken.

Authors:  Sarah E Macdonald; Pauline M van Diemen; Henny Martineau; Mark P Stevens; Fiona M Tomley; Richard A Stabler; Damer P Blake
Journal:  Infect Immun       Date:  2019-01-24       Impact factor: 3.441

2.  Genomic Comparison of Campylobacter spp. and Their Potential for Zoonotic Transmission between Birds, Primates, and Livestock.

Authors:  Allison M Weis; Dylan B Storey; Conor C Taff; Andrea K Townsend; Bihua C Huang; Nguyet T Kong; Kristin A Clothier; Abigail Spinner; Barbara A Byrne; Bart C Weimer
Journal:  Appl Environ Microbiol       Date:  2016-11-21       Impact factor: 4.792

3.  Correlation between Multilocus Sequence Typing and Antibiotic Resistance, Virulence Potential of Campylobacter jejuni Isolates from Poultry Meat.

Authors:  Xiang Wang; Qiyun Zhuo; Yi Hong; Yufan Wu; Qiang Gu; Dawei Yuan; Qingli Dong; Jingdong Shao
Journal:  Foods       Date:  2022-06-15

4.  A Cotransformation Method To Identify a Restriction-Modification Enzyme That Reduces Conjugation Efficiency in Campylobacter jejuni.

Authors:  Ximin Zeng; Zuowei Wu; Qijing Zhang; Jun Lin
Journal:  Appl Environ Microbiol       Date:  2018-11-15       Impact factor: 4.792

5.  Multilocus sequence typing confirms wild birds as the source of a Campylobacter outbreak associated with the consumption of raw peas.

Authors:  Patrick S L Kwan; Catherine Xavier; Monica Santovenia; Janet Pruckler; Steven Stroika; Kevin Joyce; Tracie Gardner; Patricia I Fields; Joe McLaughlin; Robert V Tauxe; Collette Fitzgerald
Journal:  Appl Environ Microbiol       Date:  2014-08       Impact factor: 4.792

6.  BIGSdb: Scalable analysis of bacterial genome variation at the population level.

Authors:  Keith A Jolley; Martin C J Maiden
Journal:  BMC Bioinformatics       Date:  2010-12-10       Impact factor: 3.169

7.  Finnish Campylobacter jejuni strains of multilocus sequence type ST-22 complex have two lineages with different characteristics.

Authors:  Joana Revez; Mirko Rossi; Patrik Ellström; Caroline de Haan; Hilpi Rautelin; Marja-Liisa Hänninen
Journal:  PLoS One       Date:  2011-10-24       Impact factor: 3.240

Review 8.  Biomarkers of Guillain-Barré Syndrome: Some Recent Progress, More Still to Be Explored.

Authors:  Ying Wang; Shuang Sun; Jie Zhu; Li Cui; Hong-Liang Zhang
Journal:  Mediators Inflamm       Date:  2015-09-16       Impact factor: 4.711

9.  High Prevalence of Hyper-Aerotolerant Campylobacter jejuni in Retail Poultry with Potential Implication in Human Infection.

Authors:  Euna Oh; Lynn McMullen; Byeonghwa Jeon
Journal:  Front Microbiol       Date:  2015-11-12       Impact factor: 5.640

10.  Clonal distribution and virulence of Campylobacter jejuni isolates in blood.

Authors:  Benjamin Feodoroff; Caroline P A de Haan; Patrik Ellström; Seppo Sarna; Marja-Liisa Hänninen; Hilpi Rautelin
Journal:  Emerg Infect Dis       Date:  2013-10       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.